Bioengineering Research Group

Clinical Monitoring

Dr. Michael Craven, Principal Research Fellow within Bioegnieering, is co-investigator for

Clinical-monitoring
 

RADAR-CNS collaboration which is a major research programme (2016-2022),that is developing new ways of monitoring major depressive disorder, epilepsy, and multiple sclerosis using wearable devices and smartphone technology. The monitoring platform is being developed by Kings College London as an open source software platform which is collecting longitundinal data from patients across Europe.

Dr. Craven, along with colleagues in the Division of Psychiatry & Applied Psychology (Jubliee Campus, Institute of Mental Health) is investigating the translation to clinical practice and the value proposition for RADAR-CNS. The programme receives its funding from the Innovative Medicines Initiative 2 which involves joint support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations. The main project has been recently extended with support from NIHR MindTech MedTech Co-operative and the NIHR Nottingham Biomedical Research Centre involving Prof. John Crowe, Dr. Ed Morris and Research Fellow Dr. Armando Villalon to create and run a RADAR server in the Faculty of Engineering.

This is supporting additional projects in collaboration with the Medical School, Health Sciences and Computer Science focussing on Bipolar Disorder (with an associated PhD studentship) Attention Deficit Hyperactivity Disorder and Psychosis

 

Bioengineering Research Group

The University of Nottingham
B107 Coates University Park Nottingham NG7 2RD UK


telephone: +44 (0) 115 84 66375
email:bioengineering@nottingham.ac.uk